<p>10 月 14 日（路透社）- Eyepoint Pharmaceuticals Inc (EYPT.O)：* Eyepoint Pharmaceuticals Inc - 宣佈啓動針對糖尿病性黃斑水腫的 Duravy 的第三階段項目 來源文本：進一步公司報道：（EYPT.O）</p>

EYPT

<p>10 月 14 日（路透社）- Eyepoint Pharmaceuticals Inc：* Eyepoint Pharmaceuticals Inc - 宣佈啓動針對糖尿病性黃斑水腫的 DURAVY 的第三階段項目 來源文本：進一步的公司報道：</p>

<p>Oct 14 (Reuters) - EyePoint Pharmaceuticals Inc (EYPT.O) :
* EYEPOINT PHARMACEUTICALS INC - ANNOUNCES PHASE 3 PROGRAM INITIATION FOR DURAVY IN DIABETIC MACULAR EDEMA Source text: Further company coverage: (EYPT.O)</p>
<div class="lb-trans"><p>10 月 14 日（路透社）- Eyepoint Pharmaceuticals Inc (EYPT.O)：* Eyepoint Pharmaceuticals Inc - 宣佈啓動針對糖尿病性黃斑水腫的 Duravy 的第三階段項目 來源文本：進一步公司報道：（EYPT.O）</p>
</div>

Eyepoint Pharmaceuticals 宣佈啓動 Duravy 用於治療糖尿病黃斑水腫的三期臨牀項目